• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从患者角度看家族性乳糜微粒血症综合征的负担。

The burden of familial chylomicronemia syndrome from the patients' perspective.

作者信息

Gelrud Andres, Williams Karren R, Hsieh Andrew, Gwosdow Andrea R, Gilstrap Alan, Brown Alan

机构信息

a Center for Pancreatic Disorders , University of Chicago , Chicago , IL , USA.

b Akcea Therapeutics Inc, A Subsidiary of Ionis Pharmaceuticals , Cambridge , MA , USA.

出版信息

Expert Rev Cardiovasc Ther. 2017 Nov;15(11):879-887. doi: 10.1080/14779072.2017.1372193. Epub 2017 Sep 11.

DOI:10.1080/14779072.2017.1372193
PMID:28847199
Abstract

BACKGROUND

Familial chylomicronemia syndrome (FCS) is a rare, inherited lipid disorder characterized by high levels of plasma triglycerides and chylomicrons, which may cause life-threatening acute pancreatitis. Currently no FDA-approved treatment exists. Management is low-fat diet (<20g fat/day), which is difficult to maintain. With the restricted diet, triglycerides may remain elevated. We conducted discussions with patients and caregivers to better understand the burden of FCS from their perspectives.

METHODS

A panel of FCS patients and caregivers was assembled to discuss and assess the clinical and psychosocial burden of FCS.

RESULTS

Ten adults with FCS (median age 48 yr) and their spouses/caregivers were asked specific questions about their experiences living with FCS. Patients with FCS stated their symptoms were abdominal pain, nausea, diarrhea, constipation, bloating, and fatigue. Patients reported a median of 34 episodes of acute pancreatitis over their lifetimes; half of these led to hospitalizations, each with an average stay of 6.5 days. The psychosocial burden of FCS was primarily associated with the restricted diet, anxiety and stress of FCS.

CONCLUSIONS

Living with FCS imposes a significant clinical and psychosocial burden on patients and caregivers, who reported reduced quality of life, limited employment opportunities, socialization and increased burden on family.

摘要

背景

家族性乳糜微粒血症综合征(FCS)是一种罕见的遗传性脂质紊乱疾病,其特征为血浆甘油三酯和乳糜微粒水平升高,这可能导致危及生命的急性胰腺炎。目前尚无美国食品药品监督管理局(FDA)批准的治疗方法。治疗措施为低脂饮食(<20克脂肪/天),但难以维持。在这种受限饮食情况下,甘油三酯水平可能仍会升高。我们与患者及护理人员进行了讨论,以便从他们的角度更好地了解FCS的负担。

方法

组建了一个FCS患者及护理人员小组,以讨论和评估FCS的临床及社会心理负担。

结果

询问了10名成年FCS患者(中位年龄48岁)及其配偶/护理人员关于他们与FCS共处经历的具体问题。FCS患者表示他们的症状有腹痛、恶心、腹泻、便秘、腹胀和疲劳。患者报告其一生中急性胰腺炎发作的中位数为34次;其中一半导致住院,每次平均住院6.5天。FCS的社会心理负担主要与受限饮食、FCS带来的焦虑和压力有关。

结论

与FCS共处给患者和护理人员带来了重大的临床及社会心理负担,他们报告生活质量下降、就业机会有限、社交受限以及家庭负担加重。

相似文献

1
The burden of familial chylomicronemia syndrome from the patients' perspective.从患者角度看家族性乳糜微粒血症综合征的负担。
Expert Rev Cardiovasc Ther. 2017 Nov;15(11):879-887. doi: 10.1080/14779072.2017.1372193. Epub 2017 Sep 11.
2
The burden of familial chylomicronemia syndrome: interim results from the IN-FOCUS study.家族性乳糜微粒血症综合征的负担:IN-FOCUS研究的中期结果。
Expert Rev Cardiovasc Ther. 2017 May;15(5):415-423. doi: 10.1080/14779072.2017.1311786. Epub 2017 Apr 4.
3
The burden of familial chylomicronemia syndrome in Canadian patients.加拿大患者家族性乳糜微粒血症综合征的负担。
Lipids Health Dis. 2020 Jun 2;19(1):120. doi: 10.1186/s12944-020-01302-x.
4
The burden of familial chylomicronemia syndrome: Results from the global IN-FOCUS study.家族性乳糜微粒血症综合征的负担:来自全球 IN-FOCUS 研究的结果。
J Clin Lipidol. 2018 Jul-Aug;12(4):898-907.e2. doi: 10.1016/j.jacl.2018.04.009. Epub 2018 Apr 26.
5
Familial Chylomicronemia Syndrome: A Clinical Guide For Endocrinologists.家族性乳糜微粒血症综合征:内分泌科临床指南
Endocr Pract. 2018 Aug;24(8):756-763. doi: 10.4158/EP-2018-0157.
6
Familial chylomicronemia syndrome: Bringing to life dietary recommendations throughout the life span.家族性乳糜微粒血症综合征:贯穿整个生命周期的饮食建议。
J Clin Lipidol. 2018 Jul-Aug;12(4):908-919. doi: 10.1016/j.jacl.2018.04.010. Epub 2018 Apr 27.
7
Chylomicronemia: Differences between familial chylomicronemia syndrome and multifactorial chylomicronemia.乳糜微粒血症:家族性乳糜微粒血症综合征与多因素乳糜微粒血症的差异。
Atherosclerosis. 2019 Apr;283:137-142. doi: 10.1016/j.atherosclerosis.2018.12.019. Epub 2018 Dec 28.
8
Familial chylomicronemia syndrome: A rare but devastating autosomal recessive disorder characterized by refractory hypertriglyceridemia and recurrent pancreatitis.家族性乳糜微粒血症综合征:一种罕见但严重的常染色体隐性遗传病,其特征为难治性高甘油三酯血症和反复发作的胰腺炎。
Trends Cardiovasc Med. 2020 Feb;30(2):80-85. doi: 10.1016/j.tcm.2019.03.001. Epub 2019 Mar 19.
9
The effect of volanesorsen treatment on the burden associated with familial chylomicronemia syndrome: the results of the ReFOCUS study.伏洛西奈生治疗对家族性乳糜微粒血症综合征相关负担的影响:重新聚焦研究结果
Expert Rev Cardiovasc Ther. 2018 Jul;16(7):537-546. doi: 10.1080/14779072.2018.1487290. Epub 2018 Jun 22.
10
Symptoms and impacts of familial chylomicronemia syndrome: a qualitative study of the patient experience.家族性乳糜微粒血症综合征的症状和影响:一项患者体验的定性研究。
Orphanet J Rare Dis. 2023 Oct 11;18(1):316. doi: 10.1186/s13023-023-02927-8.

引用本文的文献

1
Clinical characterization and mutation spectrum of patients with hypertriglyceridemia in a German outpatient clinic.德国一家门诊诊所中高甘油三酯血症患者的临床特征与突变谱
J Lipid Res. 2024 Jul 3;65(7):100589. doi: 10.1016/j.jlr.2024.100589.
2
Brazilian Position Statement for Familial Chylomicronemia Syndrome - 2023.2023年巴西家族性乳糜微粒血症综合征立场声明
Arq Bras Cardiol. 2023 Mar;120(4):e20230203. doi: 10.36660/abc.20230203.
3
Qualitative development of the PROMIS Profile v1.0-Familial Chylomicronemia Syndrome (FCS) 28.
PROMIS Profile v1.0-家族性乳糜微粒血症综合征(FCS)28 量表的定性开发。
Qual Life Res. 2023 Feb;32(2):605-614. doi: 10.1007/s11136-022-03266-0. Epub 2022 Oct 31.
4
Causes, clinical findings and therapeutic options in chylomicronemia syndrome, a special form of hypertriglyceridemia.乳糜微粒血症综合征(一种特殊类型的高甘油三酯血症)的病因、临床特征和治疗选择。
Lipids Health Dis. 2022 Feb 10;21(1):21. doi: 10.1186/s12944-022-01631-z.
5
The Effect of a Fat-Restricted Diet in Four Patients with Familial Chylomicronemia Syndrome: A Long-Term Follow-Up Study.低脂饮食对四名家族性乳糜微粒血症综合征患者的影响:一项长期随访研究。
Children (Basel). 2021 Nov 22;8(11):1078. doi: 10.3390/children8111078.
6
Development of a novel PRO instrument for use in familial chylomicronemia syndrome.一种用于家族性乳糜微粒血症综合征的新型患者报告结局(PRO)工具的研发。
J Patient Rep Outcomes. 2021 Aug 11;5(1):72. doi: 10.1186/s41687-021-00347-5.
7
Current Diagnosis and Management of Primary Chylomicronemia.原发性乳糜微粒血症的现行诊断与治疗。
J Atheroscler Thromb. 2021 Sep 1;28(9):883-904. doi: 10.5551/jat.RV17054. Epub 2021 May 13.
8
AAV-Mediated ApoC2 Gene Therapy: Reversal of Severe Hypertriglyceridemia and Rescue of Neonatal Death in ApoC2-Deficient Hamsters.腺相关病毒介导的载脂蛋白C2基因治疗:纠正载脂蛋白C2缺陷仓鼠的严重高甘油三酯血症并挽救新生儿死亡
Mol Ther Methods Clin Dev. 2020 Jul 15;18:692-701. doi: 10.1016/j.omtm.2020.07.011. eCollection 2020 Sep 11.
9
Analysis of a Chinese Pedigree With Familial Chylomicronemia Syndrome Reveals Two Novel Mutations by Whole-Exome Sequencing.通过全外显子组测序分析一个患有家族性乳糜微粒血症综合征的中国家系揭示了两个新突变。
Front Genet. 2020 Jul 17;11:741. doi: 10.3389/fgene.2020.00741. eCollection 2020.
10
Significant Quality of Life Improvement Observed in a Patient With FCS Associated With a Marked Reduction in Triglycerides.在一名伴有甘油三酯显著降低的家族性乳糜微粒血症患者中观察到生活质量显著改善。
J Endocr Soc. 2019 Dec 23;4(2):bvz035. doi: 10.1210/jendso/bvz035. eCollection 2020 Feb 1.